Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03766971Phase 2Suspended
Phase 2, randomised trial (2 arms), sponsored by New York State Psychiatric Institute. Primary endpoint: Cannabis self-administration at 9 days. Started Feb 2020; status: suspended.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03766971.